Advertisement
UK markets open in 51 minutes
  • NIKKEI 225

    38,587.50
    -45.52 (-0.12%)
     
  • HANG SENG

    18,073.06
    -262.26 (-1.43%)
     
  • CRUDE OIL

    82.34
    +0.17 (+0.21%)
     
  • GOLD FUTURES

    2,378.30
    +9.30 (+0.39%)
     
  • DOW

    39,134.76
    +299.90 (+0.77%)
     
  • Bitcoin GBP

    50,993.44
    -688.18 (-1.33%)
     
  • CMC Crypto 200

    1,353.71
    -6.62 (-0.49%)
     
  • NASDAQ Composite

    17,721.59
    -140.64 (-0.79%)
     
  • UK FTSE All Share

    4,508.44
    +35.07 (+0.78%)
     

Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.

Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.

A plan by Hims & Hers Health to sell legal copies of Novo Nordisk weight loss drug Wegovy is drawing pushback from the industry, and bringing new attention to an area of concern for public-health officials. Enormous demand has created shortages of Novo’s Wegovy, as well as a competing weight loss injection from Eli Lilly called Zepbound. Both companies are spending billions of dollars to increase their manufacturing capacity, but the availability of the medicines is limited in the U.S., according to the Food and Drug Administration.